Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5

Aren Bezdjian; Hanneke Bruijnzeel; Julia Pagel; Sam J Daniel; Hans G X M Thomeer

doi:10.1177/0003489418771714

Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5

Standard

Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5. / Bezdjian, Aren; Bruijnzeel, Hanneke; Pagel, Julia; Daniel, Sam J; Thomeer, Hans G X M.

In: ANN OTO RHINOL LARYN, Vol. 127, No. 6, 06.2018, p. 409-413.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Bezdjian, A, Bruijnzeel, H, Pagel, J, Daniel, SJ & Thomeer, HGXM 2018, 'Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5', ANN OTO RHINOL LARYN, vol. 127, no. 6, pp. 409-413. https://doi.org/10.1177/0003489418771714

APA

Bezdjian, A., Bruijnzeel, H., Pagel, J., Daniel, S. J., & Thomeer, H. G. X. M. (2018). Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5. ANN OTO RHINOL LARYN, 127(6), 409-413. https://doi.org/10.1177/0003489418771714

Vancouver

Bezdjian A, Bruijnzeel H, Pagel J, Daniel SJ, Thomeer HGXM. Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5. ANN OTO RHINOL LARYN. 2018 Jun;127(6):409-413. https://doi.org/10.1177/0003489418771714

Bibtex

@article{710e27285a2c46e5ad51a7f7edb1c831,

title = "Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5",

abstract = "INTRODUCTION: Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease affecting the cytotoxic pathway. Due to the recent advances in molecular diagnosis, immuno-chemo therapy, and hematopoietic stem cell transplantation treatment, FHL survival rates have drastically increased.CASE PRESENTATION: Herein, we describe a case of FHL type 5 presenting with low-frequency sensorineural hearing loss. Alongside our reported case, 6 additional patients were identified in the literature. Management and Outcome: The progressive nature of FHL disorder may cause bilateral, low-frequency, irreversible sensorineural hearing loss. This type of hearing loss should be considered among the long-term sequelea presenting with FHL5.DISCUSSION: We recommend audiological evaluation at initial FHL5 diagnosis to assess for hearing functions. Follow-up in audiology should be part of the long-term monitoring of patients with FHL5 as hearing loss could develop long after diagnosis.",

keywords = "Adult, Hearing Loss, Sensorineural/diagnosis, Humans, Lymphohistiocytosis, Hemophagocytic/complications, Male",

author = "Aren Bezdjian and Hanneke Bruijnzeel and Julia Pagel and Daniel, {Sam J} and Thomeer, {Hans G X M}",

year = "2018",

month = jun,

doi = "10.1177/0003489418771714",

language = "English",

volume = "127",

pages = "409--413",

journal = "ANN OTO RHINOL LARYN",

issn = "0003-4894",

publisher = "Annals Publishing Company",

number = "6",

}

RIS

TY - JOUR

T1 - Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5

AU - Bezdjian, Aren

AU - Bruijnzeel, Hanneke

AU - Pagel, Julia

AU - Daniel, Sam J

AU - Thomeer, Hans G X M

PY - 2018/6

Y1 - 2018/6

N2 - INTRODUCTION: Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease affecting the cytotoxic pathway. Due to the recent advances in molecular diagnosis, immuno-chemo therapy, and hematopoietic stem cell transplantation treatment, FHL survival rates have drastically increased.CASE PRESENTATION: Herein, we describe a case of FHL type 5 presenting with low-frequency sensorineural hearing loss. Alongside our reported case, 6 additional patients were identified in the literature. Management and Outcome: The progressive nature of FHL disorder may cause bilateral, low-frequency, irreversible sensorineural hearing loss. This type of hearing loss should be considered among the long-term sequelea presenting with FHL5.DISCUSSION: We recommend audiological evaluation at initial FHL5 diagnosis to assess for hearing functions. Follow-up in audiology should be part of the long-term monitoring of patients with FHL5 as hearing loss could develop long after diagnosis.

AB - INTRODUCTION: Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease affecting the cytotoxic pathway. Due to the recent advances in molecular diagnosis, immuno-chemo therapy, and hematopoietic stem cell transplantation treatment, FHL survival rates have drastically increased.CASE PRESENTATION: Herein, we describe a case of FHL type 5 presenting with low-frequency sensorineural hearing loss. Alongside our reported case, 6 additional patients were identified in the literature. Management and Outcome: The progressive nature of FHL disorder may cause bilateral, low-frequency, irreversible sensorineural hearing loss. This type of hearing loss should be considered among the long-term sequelea presenting with FHL5.DISCUSSION: We recommend audiological evaluation at initial FHL5 diagnosis to assess for hearing functions. Follow-up in audiology should be part of the long-term monitoring of patients with FHL5 as hearing loss could develop long after diagnosis.

KW - Adult

KW - Hearing Loss, Sensorineural/diagnosis

KW - Humans

KW - Lymphohistiocytosis, Hemophagocytic/complications

KW - Male

U2 - 10.1177/0003489418771714

DO - 10.1177/0003489418771714

M3 - SCORING: Journal article

C2 - 29776323

VL - 127

SP - 409

EP - 413

JO - ANN OTO RHINOL LARYN

JF - ANN OTO RHINOL LARYN

SN - 0003-4894

IS - 6

ER -